Capricor Therapeutics Inc (CAPR) News

Latest headlines that mention CAPR, newest first · each headline opens the original publisher

CAPR quote

Last price: $8.01
Day change: -1.11%
Next earnings: 2026-11-09

Quote & chart Expected move Insider trading IV rank history

CAPR headlines

last 30 days

Investing.com 17h ago

Oppenheimer reiterates Capricor stock rating on FDA data robustness

General T3CAPR OPY

Seeking Alpha News 1d ago

Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Open-Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy Transcript

General T2CAPR

Seeking Alpha 3d ago

Capricor drops as deramiocel OLE data fails to quell regulatory concerns

General T2CAPR

Investing.com 3d ago

Capricor reports 24-month data for Duchenne therapy deramiocel

General T3CAPR

Seeking Alpha 9d ago

Capricor jumps as study shows longer-term effects of deramiocel

General T2CAPR

Investing.com 21d ago

Oppenheimer reiterates Capricor stock rating ahead of trial data

General T3CAPR OPY

Investing.com 24d ago

B.Riley upgrades Capricor Therapeutics stock rating ahead of FDA date

General T3CAPR

Also mentioned with CAPR

30d

OPY2

Headlines that tag both tickers

CAPR news alerts

Get an alert by email or push when a new headline mentions CAPR.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.